Article Details

'Gateway to China' Zai Lab aims for $750M to bankroll licensing deals, clinical trials

Retrieved on: 2021-04-20 19:30:00

Tags for this article:

Click the tags to see associated articles and topics

'Gateway to China' Zai Lab aims for $750M to bankroll licensing deals, clinical trials. View article details on hiswai:

Excerpt

She left Chi-Med in 2011 to lead healthcare investments at Sequoia China, a venture capital firm that regularly invests in biotech companies.

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up